Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 111,634

Document Document Title
WO/2021/092051A1
An improved mycelium in the form of an edible aerial mycelium that is suitable for use as a food product, including a food ingredient for making mycelium-based food, such as bacon. A method of making an edible aerial mycelium suitable fo...  
WO/2021/087894A1
Disclosed are a ketoreductase mutant and a method for producing a chiral alcohol. The ketoreductase mutant has a sequence with amino acid mutations in the sequence shown in SEQ ID NO:1. The mutation sites comprise K200H. In the present i...  
WO/2021/092589A1
The disclosed subject matter provides for genetically modified cells, e.g, fungal cells, that autonomously generates and/or secretes one or more therapeutic molecules, e.g, therapeutic peptides, therapeutic proteins or small therapeutic ...  
WO/2021/090925A1
Provided are a polypeptide having excellent 4-aminobenzoic acid hydroxylation activity and a method for using the polypeptide. This polypeptide having 4-aminobenzoic acid hydroxylation activity comprises an amino acid sequence represen...  
WO/2021/088370A1
Provided is a fungal operon, an exogeneous gene site-directed quantitative fixed-time expression system based on the fungal operon, and applications of the system in expressing heterogeneous genes. The system comprises the following sequ...  
WO/2021/089636A1
The invention relates to recombinant Pseudomonas putida strains derived from P. putida KT2440 which harbor genetic modifications that make them able to produce significant amounts of polyhydroxyalkanoate (PHA) under balanced nutritional ...  
WO/2021/091474A1
The invention relates to selection of bacterial strain for use in treating serotonin deficiency and/or a disease related to serotonin deficiency by culturing bacteria of a lactic acid producing bacterial strain, under aerobic conditions,...  
WO/2021/089760A1
The present invention relates to an improved diatomaceous earth composition containing salt water. The diatomaceous earth composition according to the present invention comprises an agglomerated mixture of calcined diatomaceous earth par...  
WO/2021/089862A1
A method of extracting a cytoplasmic or periplasmic protein. The method comprises provision of a first cell suspension comprising cells, the cells containing a cytoplasmic or periplasmic protein of interest to be extracted, the first cel...  
WO/2021/089961A1
The present invention concerns a recombinant microorganism, preferably a recombinant yeast, capable of producing caffeic acid, comprising a heterologous gene coding for an enzyme of the hydrolase family capable of breaking, preferably hy...  
WO/2021/087890A1
A method for building a personalized probiotics database, and the use thereof in the screening of probiotics. The method comprises co-culturing probiotics and a biological sample, then analyzing a secretion volume of IL-10, a secretion v...  
WO/2021/088604A1
Provided is a method for continuously preparing [14/15N]-L-citrulline by means of an immobilized enzyme. The method comprises: suspending, in a packed bed reactor, a fusion protein cipA-arc formed by fixing an arginine deiminase arc to a...  
WO/2021/090787A1
The purpose of the present invention is to provide a polypeptide which has adhesiveness to endothelial cells but the adhesiveness of which to platelets is suppressed at a low level. A polypeptide that contains an elastin-like block pep...  
WO/2021/088352A1
Provided is a method for producing long-chain glycosylated genistein. The method can increase the content and the proportion of the long-chain glycosylation genistein in a reaction liquid, wherein the content of the long-chain glycosylat...  
WO/2021/088603A1
Provided is an arginine deiminase-containing genetic engineering corynebacterium glutamicum having a preservation number of CGMCC No.19404, which expresses a cipA-arc fusion protein. The engineering bacteria and the cipA-arc fusion prote...  
WO/2021/088944A1
Provided are the use of an Escherichia coli molecular chaperone GroEL/ES in the biological synthesis of a plant Rubisco and the use of an Escherichia coli molecular chaperone GroEL/ES and plant molecular chaperones Raf1, Raf2, RbcX2 and ...  
WO/2021/092249A1
Disclosed herein are compositions and methods for modifying a bacterial population. In some embodiments, described herein is a bacteriophage comprising a first nucleic acid sequence encoding a first spacer sequence or a crRNA transcribed...  
WO/2021/081676A1
Disclosed is a method for treatment of a subject having, or suspected of having, a cancer, in particular colorectal cancer, using an immune checkpoint inhibitor in combination with one or more bacteria selected from Bifidobacterium pseud...  
WO/2021/084814A1
Provided is a novel technique for more efficiently producing emulsion particles each containing a single minute particle. The present technology provides a minute particle collection method used in a minute particle-aliquoting mechanis...  
WO/2021/086487A1
Organisms resistant to horizontal gene transfer (HGT), and compositions and methods of use thereof are provided. The organisms are typically genomically recoded organisms (GRO), typically cells, having a genome in which at least one endo...  
WO/2021/082329A1
A modified-atmosphere freshness preservation method for fresh Cordyceps sinensis. The method comprises: hermetically packaging clean fresh Cordyceps sinensis with a modified-atmosphere packaging material to obtain a packaged product, whe...  
WO/2021/084526A1
A recombinant bacteria which is genetically modified to express formate dehydrogenase (FDH), phosphoribulokinase (prk) and Ribulose-Bisphosphate Carboxylase/oxygenase (RuBisCo) is disclosed. The bacteria may be modified to be autotrophic.  
WO/2021/081868A1
Disclosed is a mutant of nitrile hydratase derived from Caldalkalibacillus thermarum, which falls within the technical field of enzyme engineering. The half-life period of the nitrile hydratase mutant Cal.t Nhase-A20V provided in the pre...  
WO/2021/081648A1
A genetically engineered microorganism for the production of a cannabinoid biosynthetic pathway product is described. The genetically engineered microorganism comprises at least one nucleic acid molecule encoding at least one cannabinoid...  
WO/2021/083079A1
Provided are a long-chain composition or a combination of long-chain composition, a manufacturing method thereof, and an application thereof in manufacturing a long-chain diacid by a fermentation method. The long-chain composition compri...  
WO/2021/084159A1
The invention relates to a bacterial strain of the genus Xanthobacter and continuous culture processes for the production of protein or biomass using bacteria of the genus Xanthobacter, said process comprising supply of gases and mineral...  
WO/2021/081682A1
The invention relates to: a method for biodisintegrating scrap metal using a bacterial consortium adapted to high concentrations of iron(II) sulfate and iron(III) sulfate, deposited in the Chilean Collection of Microbial Genetic Resource...  
WO/2021/086080A1
The present invention relates to producing maltotetraose-containing oligosaccharides having a particular amount of maltotetraose.  
WO/2021/086183A1
The present invention provides a serum-free cell culture medium formulation that supports the in vitro cultivation of Mycoplasma species, especially of M. pneumoniae, and methods for cultivating Mycoplasma species in vitro, using these m...  
WO/2021/086036A1
The present invention relates to a method for fixing and stabilizing nitrogen oxide metabolites through fermentation of a nitrogen-containing natural product. The method of the present invention has optimized a fermentation condition so ...  
WO/2021/085651A1
Provided is an antibody capable of causing an antigen-antibody reaction with an epitope located in an C-terminal domain (CTD) of a ribosome protein L7/L12 in Staphylococcus aureus, wherein the C-terminal domain comprises amino acid resid...  
WO/2021/081670A1
Provided herein are enzymatic compositions for protein O-glycosylation and sialylation, methods and systems associated therewith. In particular, the composition for in vivo sialylation of therapeutic proteins. The composition comprises a...  
WO/2021/085317A1
The present invention allows cell culturing while the cells are suspended, and is configured for easy recovery of the cultured cells. An additive for suspension culture according to an embodiment is a medium additive that is added to a m...  
WO/2021/084195A1
The present invention relates to the isolated strain of Lactobacillus plantarum VF46A deposited at the CNCM (Collection Nationale De Cultures de Microorganismes, INSTITUT PASTEUR, 25 rue du Docteur Roux, F-75724 PARIS CEDEX15) under the ...  
WO/2021/085854A1
The present application relates to a novel yeast strain that produces glutathione, and a glutathione production method using same.  
WO/2021/081647A1
A genetically engineered microorganism for the production of a cannabinoid is described. The genetically engineered microorganism comprises at least one nucleic acid molecule encoding at least one cannabinoid biosynthetic pathway enzyme....  
WO/2021/082502A1
Provided is a Lactobacillus casei producing short-chain fatty acids in a high yield, a culture method therefor and an application thereof. Lactobacillus casei LC89 capable of producing short-chain fatty acids in a high yield is preserved...  
WO/2021/077231A1
Described herein is a mutant Vibrio Cholerae system for protein delivery.  
WO/2021/081031A1
The method of the disclosure comprises fermenting a gas substrate and a microorganism to generate a fermentation broth comprising the microorganism and the target component; passing the fermentation broth to a separation unit having an i...  
WO/2021/077888A1
The present invention provides a preparation method and a use method for a heavy oil viscosity reduction and degradation mixed microbial inoculum. The mixed microbial inoculum comprises Acinetobacter sp. strain ZX-15, Achromobacter pulmo...  
WO/2021/080355A1
The present application relates to a Leuconostoc citreum CJ-2B11 strain of accession number KCCM12588P, a composition comprising a Leuconostoc citreum CJ-2B11 strain of accession number KCCM12588P, and a method for producing glucose-tran...  
WO/2021/077788A1
Provided are a Yarrowia lipolytica strain and the use of same in the preparation of a low-sugar low-fat dessicated coconut nutritional powder, the deposit number of the Yarrowia lipolytica strain being GDMCC No: 60782. Mixing dessicated ...  
WO/2021/078297A1
Disclosed are an active polysaccharide compound nutrient capable of enhancing immunity and resisting fatigue and a preparation method therefor. The active polysaccharide compound nutrient comprises 10-12 parts of lentinan , 8-10 parts of...  
WO/2021/077531A1
Provided are a petroleum degradation bacteria (Falsochrobactrum sp.) TDYN1T and use thereof. The strain is deposited at the China General Microbiological Culture Collection Center with a deposit number of CGMCC No.18061. The strain can d...  
WO/2021/080537A1
With the invention, it is possible to commercialize Streptococcus thermophilus and Lactobacillus bulgaricus bacteria, which are naturally found in local village yogurts in Anatolia, after isolation and purification, and with a process de...  
WO/2021/078935A1
The invention relates to serum free media for the culture of Mycoplasma as well as to methods for the culture of Mycoplasma using the serum free culture media.  
WO/2021/077543A1
Disclosed are a linoleate isomerase and the use thereof in the production of conjugate linoleic acid, which fall within the technical fields of protein engineering and microbial engineering. A linoleate isomerase derived from Bifidobacte...  
WO/2021/078938A1
The invention relates to serum free media for the culture of Mycoplasma as well as to methods for the culture of Mycoplasma using the serum free culture media.  
WO/2021/033186A8
A method of culturing an aquaculture of an aquatic animal species of interest is disclosed. The method comprises inoculating the aquaculture with bacteria of at least one genera selected from the group consisting of Pseudomonas, Limnohab...  
WO/2021/081325A1
Improved production of recombinant proteins in E. coli, reliant on tightly controlled autoinduction, triggered by phosphate depletion in stationary phase. The process also provides an optimized autoinduction media, enabling routine batch...  

Matches 1 - 50 out of 111,634